title: Pre-emptive lidocaine inhibits arterial vasoconstriction but not vasopressin release induced by a carbon dioxide pneumoperitoneum in pigs.
abstract: BACKGROUND
  We assessed the preventive effects of i.v. or i.p. lidocaine administration on increases in vascular resistance produced by carbon dioxide pneumoperitoneum and related this to vasopressin release.
  
  
  METHODS
  Carbon dioxide pneumoperitoneum (14 mm Hg intra-abdominal pressure) was performed in 32 anaesthetized young pigs and monitored using a pulmonary artery catheter. Animals received lidocaine 0.5% (0.5 mg kg(-1)) i.v. (n=9) or 2 ml kg(-1) i.p. (n=9) or saline (n=5) 15 min before the pneumoperitoneum and were compared with a control group (n=9).
  
  
  RESULTS
  I.V. and i.p. lidocaine inhibited increases in mean systemic vascular resistance induced by the pneumoperitoneum [2109 (SD 935) and 2282 (895), respectively, vs 3013 (1067) dyne s(-1) cm(-5) in the control group]. Cardiac output was increased. Plasma lidocaine concentrations were threefold higher after i.p. administration than after i.v. administration. After pneumoperitoneum insufflation, plasma lysine-vasopressin concentrations increased in all groups (control 74%, saline 65%, i.p. lidocaine 57%, i.v. lidocaine 74%).
  
  
  CONCLUSIONS
  I.V. and i.p. lidocaine blunted systemic vascular responses to carbon dioxide pneumoperitoneum in pigs, but without influencing vasopressin release.
authors.affiliation: Department of Anaesthesiology and Critical Care DAR-B, University Hospital of Montpellier, France. gilles.boccara@psl.ap-hop-paris.fr
authors.forename: G
authors.initials: G
authors.lastname: Boccara
authors.forename: J
authors.initials: J
authors.lastname: Eliet
authors.forename: Y
authors.initials: Y
authors.lastname: Pouzeratte
authors.forename: C
authors.initials: C
authors.lastname: Mann
authors.forename: P
authors.initials: P
authors.lastname: Colson
mesh_terms: D000779:Anesthetics, Local / Q000008:administration & dosage*; D000818:Animals; D001158:Arteries / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000502:physiology*; D002302:Cardiac Output / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008012:Lidocaine / Q000008:administration & dosage* / Q000097:blood; D008236:Lypressin / Q000097:blood*; D011028:Pneumoperitoneum, Artificial / Q000009:adverse effects / Q000379:methods*; D013552:Swine; D014655:Vascular Resistance / Q000187:drug effects*; D014661:Vasoconstriction / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000097:blood*
chemical_list: D000779:Anesthetics, Local; D014662:Vasoconstrictor Agents; D002245:Carbon Dioxide; D008236:Lypressin; D008012:Lidocaine